Ledger.Open graph →
SEC Form D · filed January 10, 2024

Transition Bio, Inc

Offering
$15.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Samuel Cohen · Cambridge, MADirectorTuomas Knowles · Cambridge, MAExec · DirectorGeorge Martin · El Paso, TXExec · DirectorPreet Makkar · Cambridge, MAExecKathy Yi · Cambridge, MADirectorStephanie Torruella · Cambridge, MAExecAl Sandrock · Cambridge, MADirectorConnor Mcdermott · Cambridge, MADirectorSamuel Cohen · Cambridge, MADirectorConnor Mcdermott · Cambridge, MADirectorTuomas Knowles · Cambridge, MAExec · DirectorGeorge Martin · El Paso, TXExec · DirectorPreet Makkar · Cambridge, MAExecKathy Yi · Cambridge, MADirectorStephanie Torruella · Cambridge, MAExecAl Sandrock · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗